These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 9702183

  • 1. Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis.
    Leonardi A, Borghesan F, DePaoli M, Plebani M, Secchi AG.
    Exp Eye Res; 1998 Jul; 67(1):105-12. PubMed ID: 9702183
    [Abstract] [Full Text] [Related]

  • 2. Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis.
    Leonardi A, Jose PJ, Zhan H, Calder VL.
    Ophthalmology; 2003 Mar; 110(3):487-92. PubMed ID: 12623809
    [Abstract] [Full Text] [Related]

  • 3. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures.
    Leonardi A, Curnow SJ, Zhan H, Calder VL.
    Clin Exp Allergy; 2006 Jun; 36(6):777-84. PubMed ID: 16776679
    [Abstract] [Full Text] [Related]

  • 4. Cytokines, matrix metalloproteases, angiogenic and growth factors in tears of normal subjects and vernal keratoconjunctivitis patients.
    Leonardi A, Sathe S, Bortolotti M, Beaton A, Sack R.
    Allergy; 2009 May; 64(5):710-7. PubMed ID: 19220217
    [Abstract] [Full Text] [Related]

  • 5. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Sartori MT, Cortivo R, Dedominicis C, Saggiorato G, Abatangelo G, Secchi AG.
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-β/Smad - signalling pathway and conjunctival remodelling in vernal keratoconjunctivitis.
    Leonardi A, Di Stefano A, Motterle L, Zavan B, Abatangelo G, Brun P.
    Clin Exp Allergy; 2011 Jan; 41(1):52-60. PubMed ID: 20977504
    [Abstract] [Full Text] [Related]

  • 7. Identification of local Th2 and Th0 lymphocytes in vernal conjunctivitis by cytokine flow cytometry.
    Leonardi A, DeFranchis G, Zancanaro F, Crivellari G, De Paoli M, Plebani M, Secchi AG.
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3036-40. PubMed ID: 10549670
    [Abstract] [Full Text] [Related]

  • 8. Growth factors and collagen distribution in vernal keratoconjunctivitis.
    Leonardi A, Brun P, Tavolato M, Abatangelo G, Plebani M, Secchi AG.
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4175-81. PubMed ID: 11095612
    [Abstract] [Full Text] [Related]

  • 9. Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis.
    Leonardi A, Radice M, Fregona IA, Plebani M, Abatangelo G, Secchi AG.
    Exp Eye Res; 1999 Jun; 68(6):739-46. PubMed ID: 10375437
    [Abstract] [Full Text] [Related]

  • 10. TGF-beta1, IL-1beta, and Th2 cytokines stimulate vascular endothelial growth factor production from conjunctival fibroblasts.
    Asano-Kato N, Fukagawa K, Okada N, Kawakita T, Takano Y, Dogru M, Tsubota K, Fujishima H.
    Exp Eye Res; 2005 Apr; 80(4):555-60. PubMed ID: 15781283
    [Abstract] [Full Text] [Related]

  • 11. Immunopathogenesis of conjunctival remodelling in vernal keratoconjunctivitis.
    Abu El-Asrar AM, Al-Mansouri S, Tabbara KF, Missotten L, Geboes K.
    Eye (Lond); 2006 Jan; 20(1):71-9. PubMed ID: 15746957
    [Abstract] [Full Text] [Related]

  • 12. Increased plasma levels of substance P in vernal keratoconjunctivitis.
    Lambiase A, Bonini S, Micera A, Tirassa P, Magrini L, Bonini S, Aloe L.
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2161-4. PubMed ID: 9331280
    [Abstract] [Full Text] [Related]

  • 13. The differences of tear function and ocular surface findings in patients with atopic keratoconjunctivitis and vernal keratoconjunctivitis.
    Hu Y, Matsumoto Y, Dogru M, Okada N, Igarashi A, Fukagawa K, Tsubota K, Fujishima H.
    Allergy; 2007 Aug; 62(8):917-25. PubMed ID: 17620070
    [Abstract] [Full Text] [Related]

  • 14. Nerve growth factor has a modulatory role on human primary fibroblast cultures derived from vernal keratoconjunctivitis-affected conjunctiva.
    Micera A, Lambiase A, Stampachiacchiere B, Sgrulletta R, Normando EM, Bonini S, Bonini S.
    Mol Vis; 2007 Jun 21; 13():981-7. PubMed ID: 17653039
    [Abstract] [Full Text] [Related]

  • 15. Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis.
    Fujishima H, Takeyama M, Takeuchi T, Saito I, Tsubota K.
    Clin Exp Allergy; 1997 Apr 21; 27(4):372-8. PubMed ID: 9146929
    [Abstract] [Full Text] [Related]

  • 16. Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
    Oray M, Toker E.
    Cornea; 2013 Aug 21; 32(8):1149-54. PubMed ID: 23676782
    [Abstract] [Full Text] [Related]

  • 17. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
    Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC.
    Invest Ophthalmol Vis Sci; 2001 Sep 21; 42(10):2283-92. PubMed ID: 11527941
    [Abstract] [Full Text] [Related]

  • 18. Role of TGF-β in tissue eosinophilia associated with vernal keratoconjunctivitis.
    Ohtomo K, Ebihara N, Matsuda A, Tokura T, Funaki T, Murakami A.
    Exp Eye Res; 2010 Nov 21; 91(5):748-54. PubMed ID: 20826153
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.